(Charenton-le-Pont, France, 11 April 2018) - Transitions Optical has partnered with Johnson & Johnson Vision to make the leading light-adaptive photochromic technology available in a contact lens for the first time. Acuvue Oasys® with Transitions® Light Intelligent Technology expands the photochromic category beyond ophthalmic lenses, broadening access to the life-enhancing benefits of light management.

A range of everyday lighting situations, from artificial light to UV rays, can negatively impact eye comfort, vision and health. Acuvue Oasys® with Transitions® Light Intelligent Technology is a first of its kind contact lens, providing wearers with vision correction and a dynamic photochromic filter that helps to continuously balance the amount of light entering the eye. This contact lens quickly adjusts from clear to dark in response to changing sunlight conditions; reducing exposure to bright light indoors and outdoors, including filtering blue light and blocking UV rays.

'After twenty-eight years of innovation by Transitions Optical to bring the benefits of light management to all eyeglass wearers, resulting in the successful development of the photochromic category, we are proud to announce a new breakthrough solution that will address the unmet needs of contact lens wearers' said Laurent Vacherot, President and Chief Operating Officer of Essilor. 'Successfully achieving our mission to bring good vision to each person on the planet requires this kind of game-changing innovation. The clearance by the FDA is the first step in ensuring that a larger number of people needing vision correction can enjoy the protection and comfort of Transitions® Light Intelligent Technology, including the world's growing myopic population.'

The strategic partnership between Transitions Optical and Johnson & Johnson Vision combines the respective strengths of each company. Transitions Optical is the leading provider of photochromic (smart adaptive) lenses worldwide, while Acuvue® is the world leader in contact lenses.

Acuvue Oasys® with Transitions® Light Intelligent Technology has received 510(k) clearance from the U.S. Food and Drug Administration and is indicated for the attenuation of bright light. The two-week reusable, spherical contact lens will be commercially available in first half of 2019 from Johnson & Johnson Vision Care, Inc.

CONTACTS

Investor Relations
Véronique Gillet - Sébastien Leroy - Ariel Bauer - Alex Kleban
Tel.: +33 (0)1 49 77 42 16

Corporate Communications
Laura Viscovich
Tel.: +33 (0)1 49 77 45 02

Media Relations
Maïlis Thiercelin
Tel.: +33 (0)1 49 77 45 02

Attachments

  • Original document
  • Permalink

Disclaimer

Essilor International SA published this content on 11 April 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 11 April 2018 17:31:04 UTC